Medisch Spectrum Twente

Public research footprint of Medisch Spectrum Twente, compiled from the ClinicalTrials.gov public registry.

288

Registered studies

Active

Recruiting now

121

Completed

Stopped or withdrawn

Most-studied conditions

Heart Failure · Coronary Artery Disease (CAD) · Lung Cancer, Nonsmall Cell · Metastatic Colorectal Cancer

Recently updated registry entries

NCT06741969 — Nipocalimab in Moderate to Severe Sjogren's Disease (Active Not Recruiting)
NCT05049798 — A Study of Guselkumab and Interleukin-17 (IL-17) Inhibitor Therapies in Participants With… (Active Not Recruiting)
NCT06252649 — Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Medisch Spectrum Twente?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.